Jal Therapeutics LLC
JAL Therapeutics LLC, based in Irvine, CA, is a preclinical stage life sciences company focused on developing innovative treatments for Alzheimer's disease and other chronic conditions. The company has created a patented small molecule drug platform, featuring highly selective butyrylcholinesterase inhibitors, designed to restore acetylcholine levels while minimizing side effects.
With its lead candidate, JAL-001, demonstrating significant potential following successful animal testing, JAL Therapeutics aims to activate the cholinergic anti-inflammatory pathway to address both the symptoms and underlying mechanisms of Alzheimer's disease. The company is currently exploring licensing opportunities for its unique drug platform as it nears the completion of preclinical phase animal testing and analysis.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.